Inventiva (IVA) Change in Receivables (2020 - 2025)

Inventiva (IVA) recorded quarterly Change in Receivables of -$16.4 million in Q2 2025, down 8846.5% quarter-over-quarter from -$183347.9 in Q1 2021.

Inventiva (IVA) Change in Receivables (2020 - 2025) Analysis & Trends

Inventiva's Change in Receivables history runs 3 years deep, the most recent figure standing at -$16.4 million for Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Receivables (Qtr)
1	Alterity Therapeutics	788,338.31 Bn	788,338.28 Bn	-	-
2	Belite Bio	56,560.00 Bn	56,560.00 Bn	-	-
3	Quantum Biopharma	17,329.30 Bn	17,329.30 Bn	-	22,529.00
4	Legend Biotech	3,341.00 Bn	3,340.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,727.91 Bn	1,727.91 Bn	-	-
6	Evaxion A	1,536.68 Bn	1,536.67 Bn	-	-
7	Psyence Biomedical	238.34 Bn	238.33 Bn	-	-
8	Vertex Pharmaceuticals	113.42 Bn	106.17 Bn	2.59 Bn	-39.80 Mn
9	Abivax	95.45 Bn	95.45 Bn	-	-4.08 Mn
10	Inventiva	8.93 Mn	-259.80 Mn	-	-

Download Data